Research / TSLA / Fundamental state Inspectable configuration
State dimensions Filing 0001564590-18-026353 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
126.97% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
7.48% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
20.39% · OPTIONAL · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
48.56% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
22.33% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
6.11% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
5.14% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
3.00% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 24 states Self-history eligible
Mar 31, 2019 0/9 normalized Level 3 Jun 30, 2019 0/9 normalized Level 3 Sep 30, 2019 0/9 normalized Level 3 Dec 31, 2019 0/9 normalized Level 3 Mar 31, 2020 7/9 normalized Level 3 Jun 30, 2020 7/9 normalized Level 3 Sep 30, 2020 8/9 normalized Level 3 Dec 31, 2020 8/9 normalized Level 3 Mar 31, 2021 9/9 normalized Level 3 Jun 30, 2021 9/9 normalized Level 3 Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Dec 31, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Sep 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 215.53%
Current 126.97%
Delta -88.56% Capex Intensity Decreased
Previous 15.24%
Current 7.48%
Delta -7.76% Inventory Pressure Decreased
Previous 83.07%
Current 48.56%
Delta -34.51% Margin Increased
Previous 15.46%
Current 22.33%
Delta 6.86% Profitability Increased
Previous -15.53%
Current 6.11%
Delta 21.63% R And D Intensity Decreased
Previous 9.65%
Current 5.14%
Delta -4.51% Sbc Intensity Decreased
Previous 4.93%
Current 3.00%
Delta -1.93% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.